ATAI Life Sciences N.V. — Director's Dealing 2021

Oct 14, 2021

SEC Form 4/A — Form 4/A

Issuer: ATAI Life Sciences N.V. (ATAI)
CIK: 0001840904
Period of Report: 2021-09-10

Reporting Person: Camm Jason (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$		Common Shares (0)	0	Direct

Footnotes

F1: On September 13, 2021, a Form 4 was inadvertently filed reporting a stock option award to purchase 128,000 common shares that did not in fact occur. The Reporting Person does not own any tranche of stock options.